Tadalafil 5 mg Once Daily Improved Each IPSS Subscore, QOL, and Nocturia in Elderly BPH Patients over 70 Years Old in a Real-World Clinical Setting

Non-profit projects normally ask for donations. We don't. We will survive one way or another. If you wish to help us, please spread the word to let more people use this service.

It is delightful to see our efforts are useful to a broad range of researchers.

Links

Subjects

Tadalafil 5 mg Once Daily Improved Each IPSS Subscore, QOL, and Nocturia in Elderly BPH Patients over 70 Years Old in a Real-World Clinical Setting

Urologia Internationalis, , 1-7

Takahira Kuno, Kenji Tamura, Hideo Fukuhara, Satoshi Fukata, Shingo Ashida, Takashi Karashima, Kohji Sawada, Masaharu Yasuda, Hironobu Watanabe, Fumito Komatsu, Hajime Kuroiwa, Motoaki Saito, Keiji Inoue

Similar Articles

Urodynamic Effects of Once-Daily Tadalafil in Men with LUTS Secondary to Clinical BPH

Tadalafil improves partner QOL too

The Nocturia in BPH

Conversion From Twice-Daily to Once-Daily Tacrolimus in Stable Liver Transplant Patients: Effectiveness in a Real-World Setting

Symptoms and QOL improve with alfuzosin in BPH

Natalizumab for MS improves QOL in the clinical setting

Real-World Outcomes of Once-Daily Risperidone Dosing

Links

Subjects

Tadalafil 5 mg Once Daily Improved Each IPSS Subscore, QOL, and Nocturia in Elderly BPH Patients over 70 Years Old in a Real-World Clinical Setting

Urologia Internationalis, , 1-7Takahira Kuno, Kenji Tamura, Hideo Fukuhara, Satoshi Fukata, Shingo Ashida, Takashi Karashima, Kohji Sawada, Masaharu Yasuda, Hironobu Watanabe, Fumito Komatsu, Hajime Kuroiwa, Motoaki Saito, Keiji Inoue

Similar Articles

Urodynamic Effects of Once-Daily Tadalafil in Men with LUTS Secondary to Clinical BPH

Tadalafil improves partner QOL too

The Nocturia in BPH

Conversion From Twice-Daily to Once-Daily Tacrolimus in Stable Liver Transplant Patients: Effectiveness in a Real-World Setting

Symptoms and QOL improve with alfuzosin in BPH

Natalizumab for MS improves QOL in the clinical setting

Real-World Outcomes of Once-Daily Risperidone Dosing

Urologia Internationalis, , 1-7

Takahira Kuno, Kenji Tamura, Hideo Fukuhara, Satoshi Fukata, Shingo Ashida, Takashi Karashima, Kohji Sawada, Masaharu Yasuda, Hironobu Watanabe, Fumito Komatsu, Hajime Kuroiwa, Motoaki Saito, Keiji Inoue